One in four use weight loss drugs without doctor consultation: Researchers

| | New Delhi
  • 0

One in four use weight loss drugs without doctor consultation: Researchers

Wednesday, 18 September 2024 | Pioneer News Service | New Delhi

A team of researchers has flagged that while injectable weight loss drugs have become a popular option for people struggling with obesity, 1 in 4 or 25% consider using them without consulting their doctor, exposing themselves to several health risks.

The team from The Ohio State University, US, who surveyed 1,006 adults in America attributed the usage of drugs such as Semaglutide (Ozempic and Wegovy) without seeking medical advice to higher cost and lack of insurance.

As per the survey, at least 18 per cent participants identified cost, lack of insurance coverage (15%), difficulty obtaining a prescription (9%), and availability issues (6%) as major reasons for bypassing professional advice.

Dr Shengyi Mao, an internal medicine physician at Ohio State, underscored the risks of self-medicating. Without medical supervision, individuals may face significant health risks, such as side effects and interactions with other medications. The FDA has also issued warnings about compounded versions of Semaglutide, which can be ineffective or improperly dosed.

GLP-1 receptor agonists, like Ozempic and Wegovy, are FDA-approved for weight loss and reducing cardiovascular risk in those with obesity and existing cardiovascular conditions. However, compounded drugs may lack efficacy and present additional dangers.

Mao stressed the importance of a comprehensive approach to weight management, involving personalized medical guidance to address individual health needs and risks. Effective weight management often requires a combination of lifestyle changes and medical intervention, and discontinuing medication can lead to weight regain if not managed properly.

The U.S. FDA has approved Semaglutide for weight loss and reducing cardiovascular risk in individuals with obesity or overweight and existing cardiovascular conditions. However, the FDA has also issued warnings about compounded versions of the drug, which have been linked to dosing errors and ineffective ingredients.

State Editions

Outsourced govt employees fail to protest due to police action

03 October 2024 | Staff Reporter | Bhopal

Sitaram Adivasi adjusted in Sahariya Authority, relief to Rawat

03 October 2024 | Girish Sharma | Bhopal

Miscreant fails to snatch hand-bag, mobile phone, caught

03 October 2024 | Staff Reporter | Bhopal

23 from the State stranded in Nepal being rescued: CM

03 October 2024 | Staff Reporter | Bhopal

BHEL celebrates Gandhi Jayanti

03 October 2024 | PNS | Bhopal

AIIMS Bhopal launches ‘HBV Safe @ AIIMS Bhopal’ digital portal

03 October 2024 | Staff Reporter | Bhopal

Sunday Edition

Durga puja | A symphony of tradition and transformation

29 September 2024 | Gyaneshwar Dayal | Agenda

A Taste of Home Away from Home

29 September 2024 | SAKSHI PRIYA | Agenda

Sip the Essence of Asia: A Unique Beverages Experience

29 September 2024 | Sharmila Chand | Agenda

Moscow | A Journey Through Time: From Soviet Shadows to Modern Marvels

29 September 2024 | Gyaneshwar Dayal | Agenda

The tuning fork | Actions Have Corresponding Consequences

29 September 2024 | C V Srikanth | Agenda

Nurpur | A journey through hidden forts and spiritual treasures

22 September 2024 | Aditi Sharma | Agenda